Browsing category:

Antiparkinson Agent


Intended for patients experiencing post herpetic neuralgia, or pain after shingles, gabapentin is unique by design. Known as the brand name Gralise, which is marketed by Depomed and Abbott, this form of gabapentin is specifically made as an oral, once-a-day prescription medication, which offers 24-hour pain control for people with after-shingles pain. Gabapentin, CAS number[…]

Read More

Cases of Dementia and Alzheimer's Disease Rising, Memantine is a Viable Treatment

Memantine Hydrochloride, CAS number 41100-52-1, is an effective oral medication for treating patients with Alzheimer’s disease. Memantine is the first in a new and formidable class of Alzheimer’s drugs which work by blocking NMDA glutamate receptors. Known as it’s brand name Namenda, marketed in the United States by Forest Laboratories, memantine is typically prescribed for[…]

Read More

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. As a result, you will notice our new logo and visuals throughout the website. We’re working on updates to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service